The findings suggest that new drugs could be designed to disrupt the flow of messages between the infectious microorganisms, the Edinburgh University said in a release.
Sleeping sickness, so named because it disrupts sleep patterns, is transmitted by the bite of the tsetse fly. More than 69 million people in Africa are at risk of infection.
Untreated, it can damage the nervous system, leading to coma, organ failure and death.
During infection, the parasites - known as African trypanosomes - multiply in the bloodstream and communicate with each other by releasing a small molecule.
A team led by researchers at the University of Edinburgh was able to uncover key components of the parasites' messaging system.
They used a technique known as gene silencing to identify genes used to respond to communication signals and the mechanisms involved.
Keith Matthews, who led the research at the University's School of Biological Sciences, said: "Parasites are adept at communicating with one another to promote their survival in our bodies and ensure their spread but by manipulating their messages, new ways to combat these infections are likely to emerge."
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
